The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1658
ISSUE 1658
September 5, 2022
Issue 1658
- Prevention and Treatment of Monkeypox
- Baricitinib (Olumiant) for Severe Alopecia Areata
- Nalmefene Returns for Reversal of Opioid Overdose
- Upadacitinib (Rinvoq): A Second JAK Inhibitor for Ulcerative Colitis
- A Fixed-Dose Combination of Finasteride and Tadalafil (Entadfi) for BPH (online only)
- In Brief: Edaravone Oral Suspension (Radicava ORS) for ALS (online only)
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Prevention and Treatment of Monkeypox
September 5, 2022 (Issue: 1658)
An outbreak of monkeypox has recently spread around
the globe and across the US. Updated information
about the current outbreak is available from the CDC.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.